<DOC>
	<DOC>NCT01640730</DOC>
	<brief_summary>This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.</brief_summary>
	<brief_title>Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<criteria>confirmed (within last 3 months)progressive Stage IV NSCLC estimated life span of 3 months phase angle of at least 5 as measured by bioimpedance currently taking a lipid lowering medications has an imminently life threatening condition has preexisting liver disease known allergy to soybeans uncontrolled diabetes or uncontrolled disturbance of lipid metabolism pregnant or lactating has a pacemaker or other implantable electronic medical device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>